When hypertension outcomes were assessed in relation to baseline status, individuals with low adiponectin levels, high leptin levels, or a high L:A ratio experienced a non-significantly elevated risk of developing hypertension during the 6-year follow-up period compared with metabolically healthy normal-weight individuals. The gene discussed is ADIPOQ; the disease is hypertensive disorder.